Nevro Corp. (NVRO)
5.84
0.00 (0.00%)
Inactive · Last trade price on Apr 2, 2025
Nevro Revenue
In the year 2024, Nevro had annual revenue of $408.52M, down -3.92%. Nevro had revenue of $105.55M in the quarter ending December 31, 2024, a decrease of -9.15%.
Revenue (ttm)
$408.52M
Revenue Growth
-3.92%
P/S Ratio
0.53
Revenue / Employee
$371,718
Employees
1,099
Market Cap
221.21M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 408.52M | -16.66M | -3.92% |
Dec 31, 2023 | 425.17M | 18.81M | 4.63% |
Dec 31, 2022 | 406.37M | 19.46M | 5.03% |
Dec 31, 2021 | 386.91M | 24.86M | 6.87% |
Dec 31, 2020 | 362.05M | -28.21M | -7.23% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNVRO News
- 6 months ago - Nevro Corp. Investigated by Federman & Sherwood for Data Breach - GlobeNewsWire
- 7 months ago - NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO - Business Wire
- 8 months ago - Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results - PRNewsWire
- 9 months ago - Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - PRNewsWire
- 9 months ago - Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results - PRNewsWire
- 11 months ago - Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos - Benzinga
- 11 months ago - New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches - PRNewsWire
- 1 year ago - Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally - PRNewsWire